Home > List All Publishers > Global Markets Direct

Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

Reports
Global Markets Direct’s wide variety of reports offer a targeted solution for marketing and strategic planning. These reports include in-depth company reports such as Company Market Share reports, which give a detailed breakdown of revenues by market and region, and Company Asset Reports, which give details of companies’ key assets by geography.

Company Strategic Analysis Reports include in-depth value chain and SWOT analysis, while Company Financial Deal Profiles highlight key financial deals that have shaped the company. Global Markets Direct also produces a wide range of market reports giving access to high value unique databases of information, examples include historic and forecast asset reports and market share reports covering value, volume, distribution and company shares.

Sectors and Geographies Covered
Global Markets Direct specializes in the Energy and Medical Equipment Markets. It has a global scope, covering a broad range of countries constituting more than 90% of global revenues in each of the industries it covers.

Research Methodology
With a large dedicated research and analysis capability, Global Markets Direct employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.

List of reports from Global Markets Direct

Liver Diseases – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... for Liver Diseases, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Liver Diseases. Liver Diseases - Pipeline Review, Half Year ... \| read more...	$2,000.00
Ocular Inflammation – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... for Ocular Inflammation, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Ocular Inflammation. Ocular Inflammation - Pipeline Review, Half Year ... \| read more...	$2,000.00
Leg Ulcers – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... for Leg Ulcers, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Leg Ulcers. Leg Ulcers - Pipeline Review, Half Year ... \| read more...	$2,000.00
House Dust Mite Allergy – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... on the therapeutic development for House Dust Mite Allergy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for House Dust Mite ... \| read more...	$2,000.00
Oropharyngeal Cancer – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... for Oropharyngeal Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Oropharyngeal Cancer. Oropharyngeal Cancer - Pipeline Review, Half Year ... \| read more...	$2,000.00
Pulmonary Tuberculosis – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... for Pulmonary Tuberculosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Pulmonary Tuberculosis. Pulmonary Tuberculosis - Pipeline Review, Half Year ... \| read more...	$2,000.00
Streptococcus Pneumoniae Infection – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... therapeutic development for Streptococcus Pneumoniae Infection, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Streptococcus Pneumoniae Infection. Streptococcus Pneumoniae Infection ... \| read more...	$2,000.00
Muscle Atrophy – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... for Muscle Atrophy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Muscle Atrophy. Muscle Atrophy - Pipeline Review, Half Year ... \| read more...	$2,000.00
Metastatic Ovarian Cancer – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... therapeutic development for Metastatic Ovarian Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Metastatic Ovarian Cancer. Metastatic Ovarian Cancer ... \| read more...	$2,000.00
Influenza B Infections – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... therapeutic development for Influenza B Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Influenza B Infections. Influenza B Infections ... \| read more...	$2,000.00
Metastatic Hepatocellular Carcinoma (HCC) – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... on the therapeutic development for Metastatic Hepatocellular Carcinoma (HCC), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Metastatic Hepatocellular Carcinoma ... \| read more...	$2,000.00
Primary Systemic Amyloidosis – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... therapeutic development for Primary Systemic Amyloidosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Primary Systemic Amyloidosis. Primary Systemic Amyloidosis ... \| read more...	$2,000.00
Vitiligo – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Vitiligo. Vitiligo - Pipeline Review, Half Year is built using data and ... \| read more...	$2,000.00
Cardiac Fibrosis – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... for Cardiac Fibrosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cardiac Fibrosis. Cardiac Fibrosis - Pipeline Review, Half Year ... \| read more...	$2,000.00
Enterobacteriaceae Infections – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... for Enterobacteriaceae Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Enterobacteriaceae Infections. Enterobacteriaceae Infections - Pipeline Review, Half Year ... \| read more...	$2,000.00
Nerve Gas & Pestiside Poisioning – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... provides information on the therapeutic development for Nerve Gas & Pestiside Poisioning, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for ... \| read more...	$2,000.00
Pituitary ACTH Hypersecretion (Cushing's Disease) – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... provides information on the therapeutic development for Pituitary ACTH Hypersecretion (Cushing's Disease), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for ... \| read more...	$2,000.00
Optic Neuritis – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... for Optic Neuritis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Optic Neuritis. Optic Neuritis - Pipeline Review, Half Year ... \| read more...	$2,000.00
Disruptive Behavior Disorder – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... therapeutic development for Disruptive Behavior Disorder, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Disruptive Behavior Disorder. Disruptive Behavior Disorder ... \| read more...	$2,000.00
Paroxysmal Nocturnal Hemoglobinuria – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... therapeutic development for Paroxysmal Nocturnal Hemoglobinuria, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Paroxysmal Nocturnal Hemoglobinuria. Paroxysmal Nocturnal Hemoglobinuria ... \| read more...	$2,000.00
Sleep Apnea – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... for Sleep Apnea, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Sleep Apnea. Sleep Apnea - Pipeline Review, Half Year ... \| read more...	$2,000.00
Iron Deficiency Anemia – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... therapeutic development for Iron Deficiency Anemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Iron Deficiency Anemia. Iron Deficiency Anemia ... \| read more...	$2,000.00
Motor Neurone Diseases – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... therapeutic development for Motor Neurone Diseases, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Motor Neurone Diseases. Motor Neurone Diseases ... \| read more...	$2,000.00
Neuropathy – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Neuropathy. Neuropathy - Pipeline Review, Half Year is built using data and ... \| read more...	$2,000.00
Peptic Ulcers – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... for Peptic Ulcers, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Peptic Ulcers. Peptic Ulcers - Pipeline Review, Half Year ... \| read more...	$2,000.00

< prev 5 6 7 8 9 10 11 12 13 14 next >